Strategic Financial Concepts LLC purchased a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF (BATS:ARLU – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 51,272 shares of the company’s stock, valued at approximately $1,397,000. Strategic Financial Concepts LLC owned approximately 7.60% of AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of ARLU. Creative Financial Designs Inc. ADV acquired a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF during the third quarter valued at approximately $159,000. Harbour Investments Inc. bought a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF during the 3rd quarter worth $232,000. Foundations Investment Advisors LLC bought a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF during the 3rd quarter worth $277,000. Strategic Blueprint LLC bought a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF during the 3rd quarter worth $491,000. Finally, Cetera Investment Advisers bought a new position in AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF during the 2nd quarter worth $1,569,000.
AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF Stock Performance
Shares of ARLU stock opened at $27.99 on Tuesday. The firm has a fifty day simple moving average of $27.78 and a two-hundred day simple moving average of $27.04.
AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF Profile
The AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF (ARLU) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and uncapped gains on the SPDR S&P 500 ETF Trust over a one-year period. The actively managed fund holds options and collateral. ARLU was launched on Mar 28, 2024 and is issued by Allianz.
Featured Stories
- Five stocks we like better than AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF
- How to Invest in Biotech Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Calculate Options Profits
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AllianzIM U.S. Equity Buffer15 Uncapped Apr ETF and related companies with MarketBeat.com's FREE daily email newsletter.
